Skip to content

EEG and Pain Monitor Data Under Anesthesia to Study Pharmacodynamic Effects of Opioids and Sedatives

Pharmacodynamic Effects of Propofol and Alfentanil on EEG During Endoscopic Retrograde Cholangiopancreatography (ERCP)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07211828
Acronym
SED-ERCP
Enrollment
20
Registered
2025-10-08
Start date
2025-10-10
Completion date
2028-06-16
Last updated
2026-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, General, Cholangiopancreatography, Endoscopic Retrograde, Sedation and Analgesia

Keywords

sedation, phramacodynamics, opioid, ERCP

Brief summary

Recording and analyzing electroencephalogram (EEG) and continuous pain monitor data under anesthesia in order to investigating the pharmacodynamic effects of opioids and sedatives.

Detailed description

The Patient State Index (PSI) is the main instrument used for monitoring brain waves during anesthesia. By using conductive patches to detect frontal lobe brainwave patterns, PSI helps assess the patient's depth of anesthesia. The Analgesia Nociception Index (ANI) is a heart rate variability (HRV)-based indicator that evaluates the activity of the autonomic nervous system (sympathetic and parasympathetic), thereby reflecting the patient's pain or stress response. PSI and ANI are often used together in anesthetized patients to avoid drug overdose. Since opioids and sedative drugs interact with each other, different doses of opioids and sedatives have varying effects on brain waves, PSI, and ANI. This interaction has recently become a focus in anesthesiology and critical care medicine. The purpose of this study is to use target-controlled infusion (TCI) to continuously administer opioids and sedative drugs, and to observe changes in the Patient State Index (PSI), raw EEG, and ANI data during the anesthesia process, in order to identify the effects of opioids and sedatives on PSI, EEG, and ANI.

Interventions

DRUGhigh dose of alfentanil

The initial dose is alfentanil cet 10ng/mL and propofol 1ug/mL. Dose of alfentanil will be increased by 10ng/mL each until PSI reach to 25-50. If alfentail has been adjusted to 50 but PSI is still too high, increase propofol cet by 0.5-1ug/mL till target PSI is reached. If propofol is adjusted to 0 but PSI is still too low, decrease alfetanil by 10ng/mL The range of dosage of alfentanil is 0-50ng/mL while propofol is 0-5ug/mL.

DRUGlow dose of alfentanil with propofol

Adjust dose of propofol to the upper limit before adjusting dose of alfentanil. Increase dose of propofol 0.5-1 ug/mL in order to have PSI valued 25-50. The initial dose of propofol is 1ug/mL, alfentanil 10 ng/mL. If propofol was adjusted to cet=5 ug/mL but PSI is still too high, increase alfentanil by 10 ng/mL instead. If alfentanil was adjusted to 0 but PSI is still too low, decrease propofol by 0.5-1 ug/mL instead . The range of dosage of propofol is 0-5 ug/mL while alfentanil is 0-50ng/mL.

Sponsors

Chi Kwan Fung
Lead SponsorOTHER
National Yang Ming Chiao Tung University
CollaboratorOTHER
WeiGong Memorial Hospital
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who under go ERCP who require general anesthesia

Exclusion criteria

* ASA\> or = 4 , vulnerable groups such as prisoners, patients with physical or mental disabilities and HIV carriers

Design outcomes

Primary

MeasureTime frameDescription
EEG alpha power to beta power ratioBaseline and periprocedural
EEG alpha ratiobaseline and periprocedural
EEG delta ratiobaseline and periprocedural
EEG beta ratiobaseline and periprocedural
Patient State Index (PSI)baseline and periproceduralA processed electroencephalogram (EEG) parameter derived from frontal EEG signals. It is being measured continuously by a EEG monitor.

Secondary

MeasureTime frameDescription
Analgesia Nociception Index (ANI)Baseline and periproceduralThe Analgesia Nociception Index is measured by a continuous analgesia monitoring system . It is a numeric index (range from 0-100) indicating patients' nociception.
Blood pressurebaseline and periprocedural
Non-invasive cardiac outputduring the whole sedationCardiac output measured continuously by non-invasive monitoring (e.g., electrical cardiometry or equivalent device). The unit of measure is liters per minute (L/min)
Heart ratebaseline and periprocedural
Peripheral Capillary Oxygen Saturation (SpO₂)baseline and periproceduralContinuous non-invasive measured by pulse oximetry,
Non-invasive cardiac indexbaseline and periproceduralCardiac index calculated as cardiac output normalized to body surface area, measured non-invasively. The unit of measure is liters per minute per square meter (L/min/m²)
Non-invasive Stroke Volume (SV)baseline and periproceduralStroke volume measured non-invasively, defined as the volume of blood ejected from the left ventricle per heartbeat.

Countries

Taiwan

Contacts

CONTACTChi Kwan Boris Fung, MD
024666@tool.caaumed.org.tw886-037-676811
PRINCIPAL_INVESTIGATORChi Kwan Boris Fung, MD

Wei Gong Memorial Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026